Jaguar Health Napo And Alivus Enter New Manufacturing And Supply Agreement For Crofelemer
JAGX•New manufacturing and supply agreement
- Jaguar Health - Napo and Alivus enter new manufacturing and supply agreement for crofelemer on July 9, 2026 - SEC filing
- Jaguar Health - 2026 agreement includes minimum purchase commitment for crofelemer by Napo - SEC filing
- Jaguar Health - 2026 agreement set to expire on March 31, 2029 - SEC filing
Source text: [ID:n0001193125-26-303190]
